This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Abdominal Tuberculosis (TB) Is A Type Of TB That Affects The Abdominal Organs, Such As The Intestines, Liver, Or Spleen. It Is Caused By The Same Bacteria That Cause Pulmonary TB, Mycobacterium Tuberculosis. Abdominal TB Is Most Commonly Seen In Developing Countries, Where It Is A Leading Cause Of Death From TB. It Is Also Seen In People With A Weakened Immune System, Such As Those Infected With HIV. The Most Common Symptom Of Abdominal TB Is Abdominal Pain. Other Symptoms Can Include Weight Loss, Fever, Night Sweats, Nausea, And Vomiting. People With Abdominal TB May Also Have Symptoms Of Other Diseases, Such As Jaundice Or Anemia. Diagnosis Of Abdominal TB Is Usually Done Through A Combination Of Physical Examination, Imaging Tests, And Laboratory Tests. The Most Common Imaging Test Used Is Computed Tomography (CT) Scan. Laboratory Tests May Include A Sputum Sample, Urine Sample, And A Biopsy. Treatment Of Abdominal TB Typically Involves A Combination Of Medications. These Medications May Include Antibiotics, Such As Isoniazid And Rifampin, And Anti-Tuberculosis Drugs, Such As Ethambutol And Pyrazinamide. Surgery May Also Be Necessary If The Disease Is Advanced. It Is Important To Note That Abdominal TB Is Contagious And Can Be Spread Through Contact With An Infected Person. To Reduce The Risk Of Infection, People Should Practice Good Hygiene, Such As Washing Their Hands Regularly And Avoiding Close Contact With An Infected Person. Vaccines Are Also Available For Those Who Are At Risk For TB.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States